Prognostic factors commonly used by clinicians to assess men with prostate cancer do not adequately predict survival outcomes in Asian men living in America, according to the first comprehensive ethnic analysis of Asian-American men with prostate cancer.
As we develop, the company we keep may be increasingly influenced by our genes, according to a new study led by Virginia Commonwealth University researchers.
The American College of Physicians (ACP) this week endorsed a test project of a Patient-Centered Medical Home (PCMH). The project, to be conducted in Florida, will combine the resources of the UnitedHealth Group (UHG), the American Academy of Family Physicians (AAFP), and the American Academy of Pediatrics (AAP) with ACP to test a model that has the potential to dramatically improve healthcare delivery and quality.
As we develop, the company we keep may be increasingly influenced by our genes, according to a new study led by Virginia Commonwealth University researchers.
Visual inspection screening can reduce cervical cancer, according to a report published today by IARC and Indian scientists in The Lancet. Cervical cancer is the most common cancer in women in low-resource countries, 85% of the global cervical cancer burden of approximately 493 000 cases and 273 000 deaths being currently found in developing countries.
WHO announces the expansion of its clinical trial registry platform to include trial registers from China and India.
The first study to look at sexual function in very long-term female survivors of genital-tract cancer found that these women were pleased with the quality of their cancer care but less satisfied with the emotional support and information they received about dealing with the effects of the disease and treatment on sexuality.
High-risk patients with hypertrophic cardiomyopathy appear to have reduced risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders, according to a study in the July 25 issue of JAMA.
The medical community has been debating for many years whether, and to what extent, postmenopausal hormone therapy (HT) use is associated with a higher risk of breast cancer, says Professor Amos Pines, President of the International Menopause Society.
Individuals who receive blood transfusions from donors with undiagnosed cancers are at no higher risk of developing malignant disease than people who receive blood from donors without cancer, according to the results of a retrospective study published in The Lancet last month.